IL6 and depressive symptom measurement: Inflammatory mediators, such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), can reach brain tissue and influence the development of depression and sleep disorders by modulating synaptic transmission, neuronal excitability, neuronal survival, and synaptic plasticity (29, 30).